An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles

Cited 59 time in scopus
Metadata Downloads
An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles
E Y Moon; G H Yi; Jong Soon Kang; J S Lim; Hwan Mook Kim; S Pyo
Bibliographic Citation
Journal of Immunotoxicology, vol. 8, no. 1, pp. 56-67
Publication Year
Here, we investigated whether titanium dioxide (TiO(2)) nanoparticles affect in vivo tumor growth through the modulation of mononuclear leukocytes. In vitro lymphocyte proliferation by lipopolysaccharide (LPS) or concanavalin A (ConA) was reduced by < 25nm TiO(2) with a dose-dependent manner. Similarly, TiO(2) nanoparticles inhibited nitric oxide (NO) production from bone marrow-derived macrophages obtained from nave mice. When mice were intraperitoneally (IP) injected with < 25 or < 100nm TiO(2) once a day for 7 days, total cell number of splenocytes was reduced in the spleen of TiO(2) nanoparticle-exposed mice. Both CD4(+) and CD8(+) T-lymphocyte numbers were significantly decreased and B-lymphocyte development was retarded by host exposure to the TiO(2) nanoparticles. LPS-stimulated spleen cell proliferation was significantly reduced by host exposure to < 25 or < 100nm TiO(2), but no changes were detected in ConA-stimulated spleen cell proliferation. Further, LPS-stimulated cytokine production by peritoneal macrophages and the percentage of NK1.1(+) natural killer cells among splenocytes was reduced by the host exposures to the TiO(2) nanoparticles. When mice were IP injected with TiO(2) nanoparticles once a day for 28 days prior to the subcutaneous implantation of B16F10 melanoma cells, tumor growth was subsequently significantly increased. Collectively, these results show that TiO(2) nanoparticles may damage the development and proliferation of B- and T-lymphocytes, reduce the activity of macrophages, and decrease natural killer (NK) cell population levels, outcomes that appear to lead to an increase in tumor growth in situ. These studies allow us to suggest that TiO(2) nanoparticles might have the potential to enhance tumor growth through immunomodulation of B- and T-lymphocytes, macrophages, and NK cells.
B-lymphocyteB16F10 melanomamacrophagenanoparticlesNK cellsplenocyteT-lymphocyteTiO 2
T&F (Taylor & Francis)
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.